BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11477236)

  • 1. Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
    Radiology; 2001 Aug; 220(2):349-56. PubMed ID: 11477236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
    Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.
    Choi BI; Kim TK; Han JK; Kim AY; Seong CK; Park SJ
    Radiology; 2000 Feb; 214(2):381-6. PubMed ID: 10671584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of intratumoral vascularity in small hepatocellular carcinoma by coded phase inversion harmonics.
    Wen YL; Zhou P; Kudo M
    Intervirology; 2004; 47(3-5):169-78. PubMed ID: 15383726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors.
    Hotta N; Tagaya T; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Clin Imaging; 2005; 29(1):34-41. PubMed ID: 15859016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US.
    Lencioni R; Pinto F; Armillotta N; Bartolozzi C
    Radiology; 1996 Nov; 201(2):353-8. PubMed ID: 8888222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.
    Koda M; Matsunaga Y; Ueki M; Maeda Y; Mimura K; Okamoto K; Hosho K; Murawaki Y
    Eur Radiol; 2004 Jun; 14(6):1100-8. PubMed ID: 14676975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results.
    Kim AY; Choi BI; Kim TK; Han JK; Yun EJ; Lee KY; Han MC
    Radiology; 1998 Oct; 209(1):135-40. PubMed ID: 9769824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
    Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
    Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
    AJR Am J Roentgenol; 2001 Mar; 176(3):661-6. PubMed ID: 11222201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of vascularity in hepatic tumors: comparison of power Doppler sonography and intraarterial CO(2)-enhanced sonography.
    Chen RC; Chen WT; Tu HY; Cheng NY; Wang CK; Liao LY; Wang CS; Chen PH
    AJR Am J Roentgenol; 2002 Jan; 178(1):67-73. PubMed ID: 11756089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
    Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
    Jung EM; Clevert DA; Rupp N
    Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
    Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
    Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of hepatocellular carcinoma using digital subtraction imaging with the contrast agent, Levovist: comparison with helical CT, digital subtraction angiography, and US angiography.
    Yamamoto K; Shiraki K; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Hashimoto A; Shimizu A; Okuda Y; Nakano T
    Oncol Rep; 2002; 9(4):789-92. PubMed ID: 12066210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative comparison of tumor vascularity of hepatocellular carcinoma after intravenous contrast agent: conventional versus harmonic power Doppler US.
    Park SH; Kim TK; Lee KH; Kim AY; Choi JI; Han JK; Choi BI
    Abdom Imaging; 2001; 26(2):178-83. PubMed ID: 11178696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.